Evaluation of potential anti-RNA-dependent RNA polymerase (RdRP) drugs against the newly emerged model of COVID-19 RdRP using computational methods


Poustforoosh A., Hashemipour H., TÜZÜN B. , Pardakhty A., Mehrabani M., Nematollahi M. H.

BIOPHYSICAL CHEMISTRY, vol.272, 2021 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 272
  • Publication Date: 2021
  • Doi Number: 10.1016/j.bpc.2021.106564
  • Title of Journal : BIOPHYSICAL CHEMISTRY

Abstract

Introduction: Despite all the efforts to treat COVID-19, no particular cure has been found for this virus. Since developing antiviral drugs is a time-consuming process, the most effective approach is to evaluate the approved and under investigation drugs using in silico methods. Among the different targets within the virus structure, as a vital component in the life cycle of coronaviruses, RNA-dependent RNA polymerase (RdRP) can be a critical target for antiviral drugs. The impact of the existence of RNA in the enzyme structure on the binding affinity of anti-RdRP drugs has not been investigated so far.